Leading global pharmaceutical organizations select ArisGlobal’s AI-enabled regulatory platform to modernize Regulatory Information Management and accelerate global product development
Boston, Massachusetts, USA — July 1, 2026 — ArisGlobal, an AI-first technology company at the forefront of life sciences and creator of LifeSphere®, today announced that two additional pharmaceutical organizations have selected LifeSphere Regulatory to modernize and transform their global regulatory operations.
The organizations—one a leading global pharmaceutical company and the other a rapidly growing European specialty pharmaceutical organization—will leverage ArisGlobal’s latest AI-enabled Regulatory platform to streamline regulatory information management, improve global collaboration, accelerate submission planning and execution, and establish a future-ready foundation for intelligent regulatory operations.
LifeSphere Regulatory enables organizations to move beyond traditional RIM by connecting regulatory data, documents, and processes within a unified, intelligent environment. Embedded NavaX AI capabilities automate routine activities, surface actionable insights, and empower regulatory teams to make faster, more informed decisions while maintaining compliance across increasingly complex global markets.
“Our customers are redefining what modern regulatory operations should look like,” said Ann-Marie Orange, CIO & Global Head of R&D, ArisGlobal. “They are looking beyond digitization toward intelligent, connected operations that enable their teams to work faster, collaborate more effectively, and respond confidently to evolving global regulatory requirements. LifeSphere Regulatory delivers that foundation by combining industry-leading RIM capabilities with enterprise AI that helps organizations unlock greater productivity, improve data quality, and accelerate the delivery of therapies to patients.”
The latest customer wins further demonstrate growing market demand for AI-enabled regulatory technology as life sciences organizations seek to simplify increasingly complex regulatory processes while preparing for the next generation of intelligent automation.
LifeSphere Regulatory provides a comprehensive platform for managing the complete regulatory lifecycle—from product registration and submission planning to health authority interactions, regulatory commitments, and global change management. By unifying regulatory information across functions and geographies, organizations gain greater visibility into product portfolios, reduce manual effort, strengthen compliance, and improve operational efficiency.
These latest customer additions reinforce ArisGlobal’s continued leadership in enterprise AI for life sciences and underscore the company’s commitment to helping organizations modernize mission-critical operations with trusted, scalable, and compliant technology.
